2018 Programme Topics:

  • What is pCR and why does it matter: the clinician’s perspective
  • Handling and reporting breast specimens following neoadjuvant chemo and endocrine therapy
  • Assessment of DCIS margins and update from Sloane and Loris
  • Flat epithelial atypia and low grade neoplasia pathway
  • Approach to diagnosis of spindle cell lesions
  • Recent developments in imaging and impact on the practising pathologists
  • Learning points from MDT scenarios
  • Uncommon breast lesions:  Salivary like tumours of the breast
  • Apocrine lesions including atypia and apocrine DCIS
  • Slide seminar